Evaluation of NMDA receptors in vivo in schizophrenic patients with [123I]CNS 1261 and SPET: preliminary findings.
Bressan
Rodrigo A
RA
Institute of Psychiatry, King's College, London, WC2R 2LS, United Kingdom. r.bressan@iop.kcl.ac.uk
Erlandsson
Kjell
K
Mulligan
Rachel S
RS
Gunn
Roger N
RN
Cunningham
Vincent J
VJ
Owens
Jonathan
J
Ell
Peter J
PJ
Pilowsky
Lyn S
LS
D000465:Algorithms; D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003024:Clozapine / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D006146:Guanidines / Q000097:blood; D006801:Humans; D007091:Image Processing, Computer-Assisted; D019275:Radiopharmaceuticals / Q000097:blood; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects*; D012559:Schizophrenia / Q000000981:diagnostic imaging*; D015899:Tomography, Emission-Computed, Single-Photon
D014150:Antipsychotic Agents; C417904:CNS 1261; D018691:Excitatory Amino Acid Antagonists; D006146:Guanidines; D019275:Radiopharmaceuticals; D016194:Receptors, N-Methyl-D-Aspartate; D016291:Dizocilpine Maleate; D003024:Clozapine